AKT1 and neoplasm: Pathways activated by TGF-β1 in the TME that contribute to tumor progression and aggressive behavior also include those involving p53, the Hippo effectors YAP (yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif) and AKT [57,70,71,72].